GetTopicDetailResponse(id=4aa835e64ad, topicName=升壓藥, introduction=升壓藥, content=null, image=null, comments=0, allHits=1428, url=https://h5.medsci.cn/topic?id=35764, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=67781, tagList=[TagDto(tagId=67781, tagName=升壓藥)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2213794, encodeId=47ed2213e944f, content=<a href='/topic/show?id=fde1515116c' target=_blank style='color:#2F92EE;'>#心臟手術(shù)#</a> <a href='/topic/show?id=cd37e1767b5' target=_blank style='color:#2F92EE;'>#白蛋白#</a> <a href='/topic/show?id=4aa835e64ad' target=_blank style='color:#2F92EE;'>#升壓藥#</a> <a href='/topic/show?id=12086000374' target=_blank style='color:#2F92EE;'>#晶體液#</a>, objectTitle=心臟手術(shù)后，哪些患者應(yīng)該接受20%白蛋白進(jìn)行容量復(fù)蘇？, objectType=article, longId=833500, objectId=5ed68335004f, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240707/1720362851690_5579292.png, objectUrl=/article/show_article.do?id=5ed68335004f, replyNumber=0, likeNumber=194, createdTime=2024-07-07, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=5ed68335004f, moduleTitle=心臟手術(shù)后，哪些患者應(yīng)該接受20%白蛋白進(jìn)行容量復(fù)蘇？, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=5ed68335004f)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2196314, encodeId=3860219631458, content=<a href='/topic/show?id=4aa835e64ad' target=_blank style='color:#2F92EE;'>#升壓藥#</a> <a href='/topic/show?id=50743e26524' target=_blank style='color:#2F92EE;'>#去甲腎上腺素#</a>, objectTitle=認(rèn)識升壓藥的劑量：關(guān)注去甲腎上腺素, objectType=article, longId=817175, objectId=5f6481e175cb, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/young-people-on-medical-staff-meeting-ZFY96R4.jpg, objectUrl=/article/show_article.do?id=5f6481e175cb, replyNumber=0, likeNumber=0, createdTime=2024-03-31, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陜西省, moduleDTOList=[ModuleDTO(moduleId=5f6481e175cb, moduleTitle=認(rèn)識升壓藥的劑量：關(guān)注去甲腎上腺素, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=5f6481e175cb)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2188736, encodeId=41e32188e3689, content=<a href='/topic/show?id=21a06493a2' target=_blank style='color:#2F92EE;'>#ECMO#</a> <a href='/topic/show?id=9088501631c' target=_blank style='color:#2F92EE;'>#強心藥#</a> <a href='/topic/show?id=4aa835e64ad' target=_blank style='color:#2F92EE;'>#升壓藥#</a>, objectTitle=升壓藥和強心藥在接受ECMO支持期間的使用, objectType=article, longId=812779, objectId=a79c812e797c, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/filling-medical-history-XZB9RVX.jpg, objectUrl=/article/show_article.do?id=a79c812e797c, replyNumber=0, likeNumber=123, createdTime=2024-02-22, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=a79c812e797c, moduleTitle=升壓藥和強心藥在接受ECMO支持期間的使用, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=a79c812e797c)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2176330, encodeId=bf3e21e6330a2, content=<a href='/topic/show?id=afdd93e874f' target=_blank style='color:#2F92EE;'>#輸液#</a> <a href='/topic/show?id=0fcb4431056' target=_blank style='color:#2F92EE;'>#失血性休克#</a> <a href='/topic/show?id=4aa835e64ad' target=_blank style='color:#2F92EE;'>#升壓藥#</a>, objectTitle=當(dāng)病人出現(xiàn)失血性休克時，是選擇輸液還是升壓藥？, objectType=article, longId=805897, objectId=390b80589e52, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20221109/1668021798780_4754896.webp, objectUrl=/article/show_article.do?id=390b80589e52, replyNumber=0, likeNumber=128, createdTime=2023-12-21, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=390b80589e52, moduleTitle=當(dāng)病人出現(xiàn)失血性休克時，是選擇輸液還是升壓藥？, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=390b80589e52)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯話題小助手
2020-05-29
